Last reviewed · How we verify

NCT03783598

Person-Centered, Occupation Based Therapy for Type 2 Diabetes

Completed NA Last updated 18 February 2020
What this trial tests

NA trial testing Person centered, occupation based intervention support with problem solving therapy in Diabetes Mellitus, Type 2 in 76 participants. Completed in 27 March 2018.

Timeline
2 December 2015
Primary endpoint
2 February 2017
27 March 2018

Quick facts

Lead sponsorUskudar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment76
Start date2 December 2015
Primary completion2 February 2017
Estimated completion27 March 2018
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uskudar University

Who can join

Adults 18 to 65, any sex, with Diabetes Mellitus, Type 2 or Occupational Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to investigate the effect of a person-centered, occupation-based intervention program supported with problem-solving strategy in individuals with type 2 diabetes (T2D). Method: The study was a randomized controlled trial, that included intervention (n=33) and control group (n=34), between the ages of 18 and 65 years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Person-centred, occupation-based intervention program supported with problem-solving therapy for type 2 diabetes: a randomized controlled trial.
    Bahadır Ağce Z, Ekici G. · · 2020 · cited 11× · PMID 32746841 · DOI 10.1186/s12955-020-01521-x

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

Other Uskudar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03783598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing